Stressed to death: Implication of lymphocyte apoptosis for psychoneuroimmunology

Brain, Behavior, and Immunity

Volumn 17, Issue 1 SUPPL., 2003, Pages 18-26

  Shi, Yufang ^a,b   Devadas, Satish ^a   Greeneltch, Kristy M ^b   Yin, Deling ^b   Mufson, R Allan ^c   Zhou, Jian Nian ^a  

^a University of Medicine and Dentistry   (United States)

^b HOLLAND LABORATORY   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Apoptosis; Chronic stress; Corticosteroid; Endogenous opioids; Fas (CD95); Immunosuppression; Lymphocytes

Indexed keywords

ANTIOXIDANT; APOPTOSIS INDUCING FACTOR; CELL SURFACE RECEPTOR; ENKEPHALIN; FAS ANTIGEN; FAS LIGAND; GLUCOCORTICOID RECEPTOR ANTAGONIST; MIFEPRISTONE; MORPHINE; NALOXONE; NALTREXONE; OPIATE; OPIATE ANTAGONIST; OPIATE PEPTIDE;

ADRENALECTOMY; APOPTOSIS; CELL DEATH; CELL LOSS; CONFERENCE PAPER; DRUG MECHANISM; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE RESPONSE; IMMUNE STATUS; IMMUNITY; IMMUNOMODULATION; IMMUNOPHARMACOLOGY; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOSURVEILLANCE; LYMPHOCYTE; MENTAL STRESS; NEUROENDOCRINE SYSTEM; NEUROIMMUNOLOGY; NONHUMAN; PHYSICAL STRESS; PRIORITY JOURNAL; PROTEIN INDUCTION; RECEPTOR BLOCKING; ANIMAL; CYTOLOGY; IMMUNOLOGY; NASA DISCIPLINE REGULATORY PHYSIOLOGY; NON-NASA CENTER; PSYCHOPHYSIOLOGY; REVIEW; STRESS;

NASA DISCIPLINE REGULATORY PHYSIOLOGY; NON-NASA CENTER;

ANIMALS; APOPTOSIS; HUMANS; LYMPHOCYTES; PSYCHONEUROIMMUNOLOGY; STRESS;

EID: 0037294031     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0889-1591(02)00062-4     Document Type: Conference Paper

References (100)

1. Ader R., Cohen N. Psychoneuroimmunology: Conditioning and stress. Annu. Rev. Psychol. 44:1993;53-85.
2. Ayala A., Herdon C.D., Lehman D.L., Ayala C.A., Chaudry I.H. Differential induction of apoptosis in lymphoid tissues during sepsis: Variation in onset, frequency, and the nature of the mediators. Blood. 87:1996;4261-4275.
3. Barnes C.J., Covington B.W.t., Cameron I.L., Lee M. Effect of aging on spontaneous and induced mouse testicular germ cell apoptosis. Aging (Milano). 10:1998;497-501.
4. Bellgrau D., Gold D., Selawry H., Moore J., Franzusoff A., Duke R.C. A role for CD95 ligand in preventing graft rejection. Nature. 377:1995;630-632.
5. Berthiaume F., Aparicio C.L., Eungdamrong J., Yarmush M.L. Age- and disease-related decline in immune function: An opportunity for "thymus-boosting" therapies. Tissue Eng. 5:1999;499-514.
6. Bonneau R.H., Sheridan J.F., Feng N., Glaser R. Stress-induced modulation of the primary cellular immune response to herpes simplex virus infection is mediated by both adrenal-dependent and independent mechanisms. J. Neuroimmunol. 42:1993;167-176.
7. Brohee D., Neve P. Effect of dietary high doses of vitamin E on lymphocyte subsets in young and old CBA mice. Mech. Ageing Dev. 76:1994;189-200.
8. Cabot P.J. Immune-derived opioids and peripheral antinociception. Clin. Exp. Pharmacol. Physiol. 28:2001;230-232.
9. Capitanio J.P., Lerche N.W. Psychosocial factors and disease progression in simian AIDS: A preliminary report. AIDS. 5:1991;1103-1106.
10. Chang H.Y., Yang X. Proteases for cell suicide: Functions and regulation of caspases. Microbiol. Mol. Biol. Rev. 64:2000;821-846.
11. Chinnaiyan A.M., Dixit V.M. The cell-death machine. Curr. Biol. 6:1996;555-562.
12. Connor M., Christie M.D. Opioid receptor signalling mechanisms. Clin. Exp. Pharmacol. Physiol. 26:1999;493-499.
13. Crabtree B.L. Review of naltrexone, a long-acting opiate antagonist. Clin. Pharm. 3:1984;273-280.
14. Deeg H.J., Socie G. Malignancies after hematopoietic stem cell transplantation: Many questions, some answers. Blood. 91:1998;1833-1844.
15. DeLano R.M., Mallery S.R. Stress-related modulation of central nervous system immunity in a murine model of herpes simplex encephalitis. J. Neuroimmunol. 89:1998;51-58.
16. Delogu G., Moretti S., Antonucci A., Marcellini S., Masciangelo R., Famularo G., Signore L., De Simone C. Apoptosis and surgical trauma: Dysregulated expression of death and survival factors on peripheral lymphocytes. Arch. Surg. 135:2000;1141-1147.
17. Delogu G., Moretti S., Famularo G., Marcellini S., Santini G., Antonucci A., Marandola M., Signore L. Mitochondrial perturbations and oxidant stress in lymphocytes from patients undergoing surgery and general anesthesia. Arch. Surg. 136:2001;1190-1196.
18. Dhabhar F.S., McEwen B.S. Stress-induced enhancement of antigen-specific cell-mediated immunity. J. Immunol. 156:1996;2608-2615.
19. Dhabhar F.S., McEwen B.S. Acute stress enhances while chronic stress suppresses cell-mediated immunity in vivo: A potential role for leukocyte trafficking. Brain Behav. Immun. 11:1997;286-306.
20. Dhabhar F.S., McEwen B.S. Enhancing versus suppressive effects of stress hormones on skin immune function. Proc. Natl. Acad. Sci. USA. 96:1999;1059-1064.
21. Dominguez-Gerpe L., Rey-Mendez M. Alterations induced by chronic stress in lymphocyte subsets of blood and primary and secondary immune organs of mice. BMC Immunol. 2:2001;7.
22. Freier D.O., Fuchs B.A. Morphine-induced alterations in thymocyte subpopulations of B6C3F1 mice. J. Pharmacol. Exp. Ther. 265:1993;81-88.
23. Fuchs B.A., Pruett S.B. Morphine induces apoptosis in murine thymocytes in vivo but not in vitro: Involvement of both opiate and glucocorticoid receptors. J. Pharmacol. Exp. Ther. 266:1993;417-423.
24. Gajdos A. Opiate receptors and their natural endogenous substrates. Enkephalins, endorphins. Nouv. Presse Med. 6:1977;1865-1869.
25. Galinowski A. Stress and panic. Immunologic aspects. Encephale. 19(Spec No 1):1993;147-151.
26. Girardi M., Oppenheim D.E., Steele C.R., Lewis J.M., Glusac E., Filler R., Hobby P., Sutton B., Tigelaar R.E., Hayday A.C. Regulation of cutaneous malignancy by gammadelta T cells. Science. 294:2001;605-609.
27. Green D.R., Ware C.F. Fas-ligand: Privilege and peril. Proc. Natl. Acad. Sci. USA. 94:1997;5986-5990.
28. Grudt T.J., Williams J.T. Opioid receptors and the regulation of ion conductances. Rev. Neurosci. 6:1995;279-286.
29. Hameroff S.R. Opiate receptor pharmacology: Mixed agonist/antagonist narcotics. Contemp. Anesth. Pract. 7:1983;27-43.
30. Hug H. Fas-mediated apoptosis in tumor formation and defense. Biol. Chem. 378:1997;1405-1412.
31. Hyman S.E. Shaking out the cause of addiction. Science. 273:1996;611-612.
32. Itoh N., Yonehara S., Ishii A., Yonehara M., Mizushima S., Sameshima M., Hase A., Seto Y., Nagata S. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell. 66:1991;233-243.
33. Iwagaki H., Morimoto Y., Kodera M., Tanaka N. Surgical stress and CARS: Involvement of T cell loss due to apoptosis. Rinsho Byori. 48:2000;505-509.
34. Jefferies W.M. Cortisol and immunity. Med. Hypotheses. 34:1991;198-208.
35. Ju S.T., Panka D.J., Cui H., Ettinger R., el-Khatib M., Sherr D.H., Stanger B.Z., Marshak-Rothstein A. Fas(CD95)/FasL interactions required for programmed cell death after T- cell activation. Nature. 373:1995;444-448.
36. Kayagaki N., Yamaguchi N., Nagao F., Matsuo S., Maeda H., Okumura K., Yagita H. Polymorphism of murine Fas ligand that affects the biological activity. Proc. Natl. Acad. Sci. USA. 94:1997;3914-3919.
37. Kiecolt-Glaser J.K., McGuire L., Robles T.F., Glaser R. Psychoneuroimmunology and psychosomatic medicine: Back to the future. Psychosom. Med. 64:2002;15-28.
38. Kieffer B.L., Evans C.J. Opioid tolerance-in search of the holy grail. Cell. 108:2002;587-590.
39. Kono K., Takahashi A., Iizuka H., Fujii H., Sekikawa T., Matsumoto Y. Effect of oesophagectomy on monocyte-induced apoptosis of peripheral blood T lymphocytes. Br. J. Surg. 88:2001;1110-1116.
40. Kosterlitz H.W., Hughes J. Opiate receptors and endogenous opioid peptides in tolerance and dependence. Adv. Exp. Med. Biol. 1977;141-154.
41. Kunes P., Krejsek J. CD4 lymphopenia and postoperative immunosuppression in cardiac surgery. Cas Lek Cesk. 139:2000;361-368.
42. Lanier L.L. A renaissance for the tumor immunosurveillance hypothesis. Nat. Med. 7:2001;1178-1180.
43. Lenardo M., Chan K.M., Hornung F., McFarland H., Siegel R., Wang J., Zheng L. Mature T lymphocyte apoptosis-immune regulation in a dynamic and unpredictable antigenic environment. Annu. Rev. Immunol. 17:1999;221-253.
44. Lenardo M.J. Fas and the art of lymphocyte maintenance. J. Exp. Med. 183:1996;721-724.
45. Levine A.M., Seneviratne L., Tulpule A. Incidence and management of AIDS-related lymphoma. Oncology (Huntingt). 15:2001;629-639. discussion 639-640, 645-646.
46. Lin Y.S., Lei H.Y., Low T.L., Shen C.L., Chou L.J., Jan M.S. In vivo induction of apoptosis in immature thymocytes by staphylococcal enterotoxin B. J. Immunol. 149:1992;1156-1163.
47. Lopez M.C., Chen G.J., Colombo L.L., Huang D.S., Darban H.R., Watzl B., Watson R.R. Spleen and thymus cell subsets modified by long-term morphine administration and murine AIDS-II. Int. J. Immunopharmacol. 15:1993;909-918.
48. Madden J.J., Falek A., Donahoe R., Ketelson D., Chappel C.L. Opiate binding sites on cells of the immune system. NIDA Res. Monogr. 105:1991;103-108.
49. Maher S., Toomey D., Condron C., Bouchier-Hayes D. Activation-induced cell death: The controversial role of Fas and Fas ligand in immune privilege and tumour counterattack. Immunol. Cell Biol. 80:2002;131-137.
50. McCarthy L., Wetzel M., Sliker J.K., Eisenstein T.K., Rogers T.J. Opioids, opioid receptors, and the immune response. Drug Alcohol Depend. 62:2001;111-123.
51. McEwen B.S., Biron C.A., Brunson K.W., Bulloch K., Chambers W.H., Dhabhar F.S., Goldfarb R.H., Kitson R.P., Miller A.H., Spencer R.L., Weiss J.M. The role of adrenocorticoids as modulators of immune function in health and disease: Neural, endocrine, and immune interactions. Brain Res. Brain Res. Rev. 23:1997;79-133.
52. Meerson F.Z., Sukhikh G.T., Pletsityi K.D. Prevention of the stress-induced decrease in natural killer activity by using a. rbeta -adrenergic blocker and vitamin E Biull. Eksp. Biol. Med. 99:1985;646-647.
53. Meier P., Finch A., Evan G. Apoptosis in development. Nature. 407:2000;796-801.
54. Merino J.J., Cordero-Campana M.I. Molecular bases of the programmed cell death process: Implications of tumor suppressor protein p53 and other proteins in the control of cell cycle. Mechanisms of apoptotic action. Review. Invest. Clin. 39:1998;323-358.
55. Minton J.E. Function of the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system in models of acute stress in domestic farm animals. J. Anim. Sci. 72:1994;1891-1898.
56. Narita M., Funada M., Suzuki T. Regulations of opioid dependence by opioid receptor types. Pharmacol. Ther. 89:2001;1-15.
57. O'Brien C.P. A range of research-based pharmacotherapies for addiction. Science. 278:1997;66-70.
58. O'Connell J., Bennett M.W., O'Sullivan G.C., Collins J.K., Shanahan F. The Fas counterattack: Cancer as a site of immune privilege. Immunol. Today. 20:1999;46-52.
59. Oka M., Hirazawa K., Yamamoto K., Iizuka N., Hazama S., Suzuki T., Kobayashi N. Induction of Fas-mediated apoptosis on circulating lymphocytes by surgical stress. Ann. Surg. 223:1996;434-440.
60. Olley J.E. Opiate receptors: Ligands and methods of study. Clin. Exp. Pharmacol. Physiol. 16:1989;535-538.
61. O'Malley S.S. Opioid antagonists in the treatment of alcohol dependence: Clinical efficacy and prevention of relapse. Alcohol Alcohol. 31(Suppl 1):1996;77-81.
62. Padgett D.A., Marucha P.T., Sheridan J.F. Restraint stress slows cutaneous wound healing in mice. Brain Behav. Immun. 12:1998;64-73.
63. Pariante C.M., Carpiniello B., Orru M.G., Sitzia R., Piras A., Farci A.M., Del Giacco G.S., Piludu G., Miller A.H. Chronic caregiving stress alters peripheral blood immune parameters: The role of age and severity of stress. Psychother. Psychosom. 66:1997;199-207.
64. Pedersen B.K., Bruunsgaard H., Jensen M., Krzywkowski K., Ostrowski K. Exercise and immune function: Effect of ageing and nutrition. Proc. Nutr. Soc. 58:1999;733-742.
65. Pedersen B.K., Bruunsgaard H., Klokker M., Kappel M., MacLean D.A., Nielsen H.B., Rohde T., Ullum H., Zacho M. Exercise-induced immunomodulation - possible roles of neuroendocrine and metabolic factors. Int. J. Sports Med. 18(Suppl 1):1997;S2-S7.
66. Rabin B.S., Cohen S., Ganguli R., Lysle D.T., Cunnick J.E. Bidirectional interaction between the central nervous system and the immune system. Crit. Rev. Immunol. 9:1989;279-312.
67. Rabkin C.S. Association of non-acquired immunodeficiency syndrome-defining cancers with human immunodeficiency virus infection. J. Natl. Cancer Inst. Monogr. 23:1998;23-25.
68. Rich T., Watson C.J., Wyllie A. Apoptosis: The germs of death. Nat. Cell Biol. 1:1999;E69-E71.
69. Roshal M., Zhu Y., Planelles V. Apoptosis in AIDS. Apoptosis. 6:2001;103-116.
70. Roy S., Loh H.H. Effects of opioids on the immune system. Neurochem. Res. 21:1996;1375-1386.
71. Roy S., Loh H.H., Lee N.M. Dynorphin blocks opioid inhibition of macrophage-colony stimulating factor-induced proliferation of bone marrow cells. Eur. J. Pharmacol. 202:1991;355-359.
72. Roy S., Ramakrishnan S., Loh H.H., Lee N.M. Chronic morphine treatment selectively suppresses macrophage colony formation in bone marrow. Eur. J. Pharmacol. 195:1991;359-363.
73. Roy S., Wang J.H., Balasubramanian S., Sumandeep, Charboneau R., Barke R., Loh H.H. Role of hypothalamic-pituitary axis in morphine-induced alteration in thymic cell distribution using μ-opioid receptor knockout mice. J. Neuroimmunol. 116:2001;147-155.
74. Salzet M., Vieau D., Day R. Crosstalk between nervous and immune systems through the animal kingdom: Focus on opioids. Trends Neurosci. 23:2000;550-555.
75. Schroeder S., Lindemann C., Decker D., Klaschik S., Hering R., Putensen C., Hoeft A., von Ruecker A., Stuber F. Increased susceptibility to apoptosis in circulating lymphocytes of critically ill patients. Langenbecks Arch. Surg. 386:2001;42-46.
76. Sei Y., Yoshimoto K., McIntyre T., Skolnick P., Arora P.K. Morphine-induced thymic hypoplasia is glucocorticoid-dependent. J. Immunol. 146:1991;194-198.
77. Sharma K., Wang R.X., Zhang L.Y., Yin D.L., Luo X.Y., Solomon J.C., Jiang R.F., Markos K., Davidson W., Scott D.W., Shi Y.F. Death the Fas way: Regulation and pathophysiology of CD95 and its ligand. Pharmacol. Ther. 88:2000;333-347.
78. Sheridan J.F., Dobbs C., Jung J., Chu X., Konstantinos A., Padgett D., Glaser R. Stress-induced neuroendocrine modulation of viral pathogenesis and immunity. Ann. N.Y. Acad. Sci. 840:1998;803-808.
79. Shi Y.F., Bissonnette R.P., Parfrey N., Szalay M., Kubo R.T., Green D.R. In vivo administration of monoclonal antibodies to the CD3 T cell receptor complex induces cell death (apoptosis) in immature thymocytes. J. Immunol. 146:1991;3340-3346.
80. Shi Y.F., Sahai B.M., Green D.R. Cyclosporin A inhibits activation-induced cell death in T-cell hybridomas and thymocytes. Nature. 339:1989;625-626.
81. Singh A., Failla M.L., Deuster P.A. Exercise-induced changes in immune function: Effects of zinc supplementation. J. Appl. Physiol. 76:1994;2298-2303.
82. Smith C.A., Williams G.T., Kingston R., Jenkinson E.J., Owen J.J. Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature. 337:1989;181-184.
83. Stefano G.B. Autoimmunovascular regulation: Morphine and anandamide and ancondamide stimulated nitric oxide release. J. Neuroimmunol. 83:1998;70-76.
84. Swinnen L.J. Transplantation-related lymphoproliferative disorder: A model for human immunodeficiency virus-related lymphomas. Semin. Oncol. 27:2000;402-408.
85. Sytwu H.K., Liblau R.S., McDevitt H.O. The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. Immunity. 5:1996;17-30.
86. Takahashi T., Tanaka M., Brannan C.I., Jenkins N.A., Copeland N.G., Suda T., Nagata S. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell. 76:1994;969-976.
87. Takahashi T., Tanaka M., Inazawa J., Abe T., Suda T., Nagata S. Human Fas ligand: Gene structure, chromosomal location and species specificity. Int. Immunol. 6:1994;1567-1574.
88. Vaccarino A.L., Kastin A.J. Endogenous opiates: 1999. Peptides. 21:2000;1975-2034.
89. Venkatraman J.T., Pendergast D.R. Effect of dietary intake on immune function in athletes. Sports Med. 32:2002;323-337.
90. Wang J., Charboneau R., Balasubramanian S., Barke R.A., Loh H.H., Roy S. Morphine modulates lymph node-derived T lymphocyte function: Role of caspase-3, -8, and nitric oxide. J. Leukoc. Biol. 70:2001;527-536.
91. Wang R., Zhang L., Yin D., Mufson R.A., Shi Y. Protein kinase C regulates Fas (CD95/APO-1) expression. J. Immunol. 161:1998;2201-2207.
92. Watanabe-Fukunaga R., Brannan C.I., Itoh N., Yonehara S., Copeland N.G., Jenkins N.A., Nagata S. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J. Immunol. 148:1992;1274-1279.
93. Wei L.N., Loh H.H. Regulation of opioid receptor expression. Curr. Opin. Pharmacol. 2:2002;69-75.
94. Wesselborg S., Janssen O., Kabelitz D. Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells. J. Immunol. 150:1993;4338-4345.
95. Wyllie A.H. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature. 284:1980;555-556.
96. Yin D., Mufson R.A., Wang R., Shi Y. Fas-mediated cell death promoted by opioids. Nature. 397:1999;218.
97. Yin D., Tuthill D., Mufson R.A., Shi Y. Chronic restraint stress promotes lymphocyte apoptosis by modulating CD95 expression. J. Exp. Med. 191:2000;1423-1428.
98. Zaki P.A., Bilsky E.J., Vanderah T.W., Lai J., Evans C.J., Porreca F. Opioid receptor types and subtypes: The δ receptor as a model. Annu. Rev. Pharmacol. Toxicol. 36:1996;379-401.
99. Zakowski S.G., McAllister C.G., Deal M., Baum A. Stress, reactivity, and immune function in healthy men. Health Psychol. 11:1992;223-232.
100. Zorrilla E.P., Luborsky L., McKay J.R., Rosenthal R., Houldin A., Tax A., McCorkle R., Seligman D.A., Schmidt K. The relationship of depression and stressors to immunological assays: A meta-analytic review. Brain Behav. Immun. 15:2001;199-226.